- Home
- NEE vs AZN Comparison
NEE vs AZN Comparison
Compare NEE & AZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | NEE | AZN |
|---|---|---|
| Founded | 1925 | 1992 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Electric Utilities: Central | Biotechnology: Pharmaceutical Preparations |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 193.1B | 285.7B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | NEE | AZN |
|---|---|---|
| Price | $91.10 | $194.18 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 13 | 1 |
| Target Price | ★ $93.38 | N/A |
| AVG Volume (30 Days) | ★ 8.6M | 2.2M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 2.73% | 1.62% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $14.41 | $9.84 |
| Revenue Next Year | $8.48 | $6.16 |
| P/E Ratio | ★ $27.64 | $31.91 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $61.72 | $61.24 |
| 52 Week High | $95.91 | $212.71 |
Technical Indicators
Market Signals| Indicator | NEE | AZN |
|---|---|---|
| Relative Strength Index (RSI) | 51.61 | 61.35 |
| Support Level | $79.30 | $89.28 |
| Resistance Level | $95.91 | $211.32 |
| Average True Range (ATR) | 2.15 | 3.26 |
| MACD | -0.55 | -5.05 |
| Stochastic Oscillator | 21.10 | 7.77 |
Price Performance
Historical ComparisonAbout NEE NextEra Energy Inc.
NextEra Energy's regulated utility, Florida Power & Light, is the largest rate-regulated utility in Florida. The utility distributes power to over 6 million customer accounts in Florida and owns 36 gigawatts of generation. FP&L contributes roughly 70% of NextEra's consolidated operating earnings. NextEra Energy Resources, the renewable energy segment, generates and sells power throughout the United States and Canada with nearly 40 GW of generation capacity, including natural gas, nuclear, wind, and solar.
About AZN AstraZeneca PLC
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (about 40% of total revenue), cardiovascular, renal, and metabolic (25%), rare disease (17%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one third of its sales.